205 related articles for article (PubMed ID: 22490042)
1. Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury.
Bae SH; Sung SH; Lee HE; Kang HT; Lee SK; Oh SY; Woo HA; Kil IS; Rhee SG
Antioxid Redox Signal; 2012 Nov; 17(10):1351-61. PubMed ID: 22490042
[TBL] [Abstract][Full Text] [Related]
2. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG
Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188
[TBL] [Abstract][Full Text] [Related]
3. Study of the signaling function of sulfiredoxin and peroxiredoxin III in isolated adrenal gland: unsuitability of clonal and primary adrenocortical cells.
Kil IS; Bae SH; Rhee SG
Methods Enzymol; 2013; 527():169-81. PubMed ID: 23830631
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial H
Rhee SG; Kil IS
Free Radic Biol Med; 2016 Nov; 100():73-80. PubMed ID: 28236420
[TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
7. Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency.
Lu Y; Gong P; Cederbaum AI
Toxicology; 2008 Oct; 252(1-3):9-16. PubMed ID: 18721845
[TBL] [Abstract][Full Text] [Related]
8. Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia.
Shi S; Guo Y; Lou Y; Li Q; Cai X; Zhong X; Li H
Exp Cell Res; 2017 Mar; 352(2):273-280. PubMed ID: 28202395
[TBL] [Abstract][Full Text] [Related]
9. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia.
Bae SH; Woo HA; Sung SH; Lee HE; Lee SK; Kil IS; Rhee SG
Antioxid Redox Signal; 2009 May; 11(5):937-48. PubMed ID: 19086807
[TBL] [Abstract][Full Text] [Related]
10. Redox regulation of lipopolysaccharide-mediated sulfiredoxin induction, which depends on both AP-1 and Nrf2.
Kim H; Jung Y; Shin BS; Kim H; Song H; Bae SH; Rhee SG; Jeong W
J Biol Chem; 2010 Nov; 285(45):34419-28. PubMed ID: 20826812
[TBL] [Abstract][Full Text] [Related]
11. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression.
Jeong W; Bae SH; Toledano MB; Rhee SG
Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055
[TBL] [Abstract][Full Text] [Related]
12. Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2.
Baek JY; Han SH; Sung SH; Lee HE; Kim YM; Noh YH; Bae SH; Rhee SG; Chang TS
J Biol Chem; 2012 Jan; 287(1):81-89. PubMed ID: 22086924
[TBL] [Abstract][Full Text] [Related]
13. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
Chawsheen HA; Jiang H; Ying Q; Ding N; Thapa P; Wei Q
J Biol Chem; 2019 May; 294(22):8991-9006. PubMed ID: 31000628
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages.
Abbas K; Breton J; Planson AG; Bouton C; Bignon J; Seguin C; Riquier S; Toledano MB; Drapier JC
Free Radic Biol Med; 2011 Jul; 51(1):107-14. PubMed ID: 21466852
[TBL] [Abstract][Full Text] [Related]
15. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
Kim H; Lee GR; Kim J; Baek JY; Jo YJ; Hong SE; Kim SH; Lee J; Lee HI; Park SK; Kim HM; Lee HJ; Chang TS; Rhee SG; Lee JS; Jeong W
Free Radic Biol Med; 2016 Feb; 91():264-74. PubMed ID: 26721593
[TBL] [Abstract][Full Text] [Related]
16. Circadian Oscillation of Sulfiredoxin in the Mitochondria.
Kil IS; Ryu KW; Lee SK; Kim JY; Chu SY; Kim JH; Park S; Rhee SG
Mol Cell; 2015 Aug; 59(4):651-63. PubMed ID: 26236015
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial H
Rhee SG; Kil IS
Free Radic Biol Med; 2016 Oct; 99():120-127. PubMed ID: 27497909
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Wu L; Jiang H; Chawsheen HA; Mishra M; Young MR; Gerard M; Toledano MB; Colburn NH; Wei Q
Carcinogenesis; 2014 May; 35(5):1177-84. PubMed ID: 24503444
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
Wang X; Wu D; Yang L; Cederbaum AI
Hepatology; 2011 Nov; 54(5):1753-66. PubMed ID: 21748763
[TBL] [Abstract][Full Text] [Related]
20. Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Wei Q; Jiang H; Xiao Z; Baker A; Young MR; Veenstra TD; Colburn NH
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7004-9. PubMed ID: 21487000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
